Strategy Asset Managers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
6,100
+1,159
+23% +$250K 0.21% 81
2025
Q4
$1.02M Buy
4,941
+6
+0.1% +$1.13K 0.17% 89
2025
Q3
$775K Buy
+4,935
New +$762K 0.14% 111
2024
Q3
Sell
-9,434
Closed -$892K 254
2024
Q2
$892K Buy
9,434
+2,352
+33% +$240K 0.2% 86
2024
Q1
$792K Buy
7,082
+220
+3% +$23.7K 0.17% 97
2023
Q4
$692K Sell
6,862
-805
-10% -$79.9K 0.16% 97
2023
Q3
$666K Sell
7,667
-1,767
-19% -$160K 0.17% 96
2023
Q2
$892K Buy
9,434
+627
+7% +$53K 0.2% 86
2023
Q1
$665K Buy
+8,807
New +$664K 0.16% 113

Other funds holding CAH

Strategy Asset Managers's CAH Position: Q1 2026 in Review

Strategy Asset Managers increased its Cardinal Health (CAH) stake by 23% in Q1 2026, buying an estimated $250K and bringing the position to 6,100 shares worth $1.29M. The position accounts for 0.21% of the portfolio, ranked #81.

Strategy Asset Managers first reported a position in CAH in Q1 2023 and has held it in 9 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Strategy Asset Managers held 6,100 shares of Cardinal Health worth $1.29M as of Q1 2026.
  • Strategy Asset Managers bought 1,159 Cardinal Health shares in Q1 2026, an estimated $250K.
  • Cardinal Health made up 0.21% of Strategy Asset Managers's portfolio in Q1 2026, its #81 holding.
  • Strategy Asset Managers first reported a position in Cardinal Health in Q1 2023 and has held it in 9 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.